Gilles G.

The investigator is active in onco-hematology with a strong focus on acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, multiple myeloma, and lymphoma. Additional interests include myelodysplastic syndrome, myeloproliferative neoplasms, polycythemia vera, and primary myelofibrosis, alongside complex entities such as Richter’s syndrome and peripheral T-cell lymphoma.

• Acute and chronic leukemias
• Lymphoma subtypes and Richter transformation
• Multiple myeloma and plasma cell disorders
• Myelodysplastic and myeloproliferative diseases

Therapeutic interests include targeted approaches, immunotherapy, and transplant-related strategies in blood cancers.

Research activity includes non-small cell lung cancer, metastatic breast cancer, colorectal cancer, ovarian cancer, bladder cancer, and neuroendocrine carcinoma. The investigator also works on pancreatic and ampullary adenocarcinoma, with attention to advanced disease, postoperative settings, and treatment-resistant tumor profiles.

• Non-small cell lung cancer
• Breast and colorectal cancer
• Ovarian and pancreatic malignancies
• Genomically defined and advanced solid tumors

These studies reflect involvement in precision oncology, perioperative treatment, and systemic therapy selection for difficult-to-treat cancers.

Clinical interests span acute myocardial infarction, heart failure, cardiac arrest, atherosclerosis, hypercholesterolemia, stroke, and transient ischemic attack. The investigator also contributes to research in post-resuscitation syndrome, intracerebral hemorrhage, and septic shock, linking cardiovascular care with intensive care medicine.

• Acute coronary syndromes and myocardial injury
• Heart failure and lipid disorders
• Stroke and intracranial hemorrhage
• Cardiac arrest and intensive care syndromes

Therapeutic work also includes antithrombotic, lipid-lowering, and resuscitation-focused interventions.

Additional research spans sepsis, respiratory syncytial virus prevention, Mycobacterium avium complex infection, candidemia, and ventilator-associated infection. Autoimmune and systemic inflammatory interests include lupus erythematosus, giant cell arteritis, familial Mediterranean fever, and Hidradenitis suppurativa, together with metabolic conditions such as type 2 diabetes and metabolic dysfunction-associated steatohepatitis.

• Severe bacterial and viral infections
• Systemic autoimmune and autoinflammatory disease
• Metabolic liver disease
• Prevention of respiratory infections

Therapeutic involvement extends across immunomodulation, anti-infective care, and disease prevention in high-risk medical settings.